Erucin

Erucin

SCHEMBL435774

CSCCCCN=C=S

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5352877 0.98 TRPA1 (1.00)
SCHEMBL3123984 0.98 TRPA1 (1.00)
SCHEMBL3115548 0.98 TRPA1 (1.00)
SCHEMBL1020887 0.98 TRPA1 (1.00)
SCHEMBL2679812 0.98 TRPA1 (1.00)
SCHEMBL25332310 0.98 TRPA1 (1.00)
SCHEMBL668271 0.93
Erucin SCHEMBL7579439 0.82 TRPA1 (0.68)
SCHEMBL10585683 0.82
SCHEMBL28836397 0.80 TRPA1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020021544-A1 CANNABIDIOL AND METHYLTHIO-BUTYL-ISOTHIOCYANATE FOR TREATING INFLAMMATORY DISEASES BOL PHARMA LTD. (IL) 2020-01-30 WO claimed
US-20120208879-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS GAVISH-GALILEE BIO APPLICATIONS LTD. (IL) 2012-08-16 US claimed
US-8158161-B2 Methods and pharmaceutical compositions useful for treating psoriasis S.U.L.V.E. LTD. (IL) 2012-04-17 US claimed
US-20100260737-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2010-10-14 US claimed
EP-2229166-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT Alma Mater Studiorum - Università di Bologna (IT) 2010-09-22 EP claimed
EP-2163238-A2 Compound for lightening skin tone comprising sulforaphane or sulforaphene or their derivates Henkel AG & Co. KGaA (DE) 2010-03-17 EP claimed
WO-2010001096-A2 TREATMENT PROVEXIS NATURAL PRODUCTS LIMITED (GB) 2010-01-07 WO claimed
WO-2009083871-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2009-07-09 WO claimed
US-20080044497-A1 Methods and Pharmaceutical Compositions Useful for Treating Psoriasis S.U.L.V.E. LTD. (IL) 2008-02-21 US claimed
EP-1841320-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS S.U.L.V.E. Ltd. (IL) 2007-10-10 EP claimed
WO-2006075330-A2 METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS S.U.L.V.E. LTD. (IL) 2006-07-20 WO claimed
WO-2002087388-A1 CONTAINER FOR CLEANING IMPLEMENTS, IN ADDITION TO AN INSERTION BODY, TOOTHBRUSH AND RESERVOIR NEUFELD KLAUS (AT) 2002-11-07 WO claimed
US-12590057-B2 Crystalline complexes Theracryf PLC (GB) 2026-03-31 US disclosed
US-12507698-B2 Use of an extract of part of a rocket plant for stimulating the defenses of plants and trees and associated composition and method ELICIR (FR) 2025-12-30 US disclosed
US-20250197898-A1 ISOTHIOCYANATE CONTAINING BRASSICACEAE PRODUCTS AND METHOD OF PREPARATION THEREOF COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2025-06-19 US disclosed
WO-2025069039-A1 AN IN SITU PROCESS FOR THE PREPARATION OF PRIMARY AMINE COMPOUNDS SAMANT RAJARAM (IN) 2025-04-03 WO disclosed
US-5411986-A Chemoprotective isothiocyanates THE JOHNS HOPKINS UNIVERSITY (US) 1995-05-02 US disclosed
WO-1994019948-A9 CHEMOPROTECTIVE ISOTHIOCYANATES 1994-11-10 WO disclosed
WO-1994019948-A1 CHEMOPROTECTIVE ISOTHIOCYANATES CHO CHEON GYU (US) 1994-09-15 WO disclosed
US-3932318-A COPOLYMERS WITH ISOCYANATES, CRYOGENIC POLYMERIZATION, NONFLAMMABLE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-01-13 US disclosed